Compro

   
Google
 
Web NewDrugInformation.com

Compro


Drug - Compro
The trade name of the product as shown on the labeling.

Dosage - SUPPOSITORY; RECTAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Prochlorperazine
Multiple ingredients are in alphabetical order.

Strength - 25MG
The potency of the active ingredient(s), Prochlorperazine. May repeat for multiple part products.

Applicant - PADDOCK
The firm name holding legal responsibility for Compro. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 040246
The FDA assigned number to Compro. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Compro. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code - AB
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Jun 28, 2000
The date Compro was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Compro. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Compro is in. Format is RX, OTC, DISCN.

Applicant Full Name - Paddock Laboratories Inc
The full name of the firm holding legal responsibility for the new application of Compro.

Compro